RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kyorin Pharmaceutical Co Stock

Kyorin Pharmaceutical Co Net Income 2024

Kyorin Pharmaceutical Co Net Income

5.32 B JPY

Ticker

4569.T

ISIN

JP3247090008

In 2024, Kyorin Pharmaceutical Co's profit amounted to 5.32 B JPY, a 12.68% increase from the 4.72 B JPY profit recorded in the previous year.

The Kyorin Pharmaceutical Co Net Income history

YEARNET INCOME (undefined JPY)
2027e4.59
2026e5
2025e5.21
20245.32
20234.72
20223.93
20216.13
20206.15
20196.87
20186.57
20177.31
201613.64
201512.06
201412.03
201312.42
20129.23
201110.93
20108.85
20092.04
20082.19
20074.84
20060.02
20050.13

Kyorin Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Kyorin Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Kyorin Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Kyorin Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Kyorin Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Kyorin Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Kyorin Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Kyorin Pharmaceutical Co’s growth potential.

Kyorin Pharmaceutical Co Revenue, EBIT and net profit per share

DateKyorin Pharmaceutical Co RevenueKyorin Pharmaceutical Co EBITKyorin Pharmaceutical Co Net Income
2027e125.28 B undefined0 undefined4.59 B undefined
2026e128.1 B undefined0 undefined5 B undefined
2025e126.48 B undefined0 undefined5.21 B undefined
2024119.53 B undefined6.01 B undefined5.32 B undefined
2023113.27 B undefined5.12 B undefined4.72 B undefined
2022105.53 B undefined5 B undefined3.93 B undefined
2021102.9 B undefined5.77 B undefined6.13 B undefined
2020109.98 B undefined7.49 B undefined6.15 B undefined
2019113.62 B undefined8.96 B undefined6.87 B undefined
2018110.64 B undefined8.81 B undefined6.57 B undefined
2017115.37 B undefined10.41 B undefined7.31 B undefined
2016119.48 B undefined19.64 B undefined13.64 B undefined
2015113.12 B undefined14.74 B undefined12.06 B undefined
2014111.4 B undefined17.61 B undefined12.03 B undefined
2013107.03 B undefined17.95 B undefined12.42 B undefined
2012103.23 B undefined14.46 B undefined9.23 B undefined
2011104.07 B undefined16.44 B undefined10.93 B undefined
201099.76 B undefined13.26 B undefined8.85 B undefined
200990.89 B undefined8.95 B undefined2.04 B undefined
200881.07 B undefined5.87 B undefined2.19 B undefined
200777.09 B undefined8.05 B undefined4.84 B undefined
2006366 M undefined143 M undefined20 M undefined
20053.38 B undefined-220 M undefined133 M undefined

Kyorin Pharmaceutical Co stock margins

The Kyorin Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Kyorin Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Kyorin Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Kyorin Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Kyorin Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Kyorin Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Kyorin Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Kyorin Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Kyorin Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Kyorin Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Kyorin Pharmaceutical Co Margin History

Kyorin Pharmaceutical Co Gross marginKyorin Pharmaceutical Co Profit marginKyorin Pharmaceutical Co EBIT marginKyorin Pharmaceutical Co Profit margin
2027e43.01 %0 %3.67 %
2026e43.01 %0 %3.9 %
2025e43.01 %0 %4.12 %
202443.01 %5.02 %4.45 %
202344.29 %4.52 %4.17 %
202246.85 %4.74 %3.73 %
202150.17 %5.61 %5.96 %
202051.86 %6.81 %5.59 %
201950.53 %7.88 %6.05 %
201855.65 %7.96 %5.94 %
201755.93 %9.03 %6.33 %
201660.36 %16.43 %11.42 %
201558.81 %13.03 %10.66 %
201461.36 %15.81 %10.79 %
201362.5 %16.77 %11.61 %
201264.23 %14.01 %8.94 %
201163.91 %15.8 %10.5 %
201062.43 %13.29 %8.87 %
200959.52 %9.85 %2.24 %
200860.35 %7.24 %2.7 %
200759.81 %10.45 %6.28 %
2006100 %39.07 %5.46 %
200536.23 %-6.51 %3.94 %

Kyorin Pharmaceutical Co Aktienanalyse

What does Kyorin Pharmaceutical Co do?

Kyorin Holdings Inc is a Japanese holding company that was founded in September 2007. However, the company's history dates back to 1947 when Kyorin Pharmaceutical Co., Ltd. was established. Kyorin Holdings is a diversified company that operates in various sectors and business areas. The company's main activities include the development, production, and marketing of pharmaceutical products, medical devices, and healthcare products. In the pharmaceutical sector, Kyorin has been active since its inception. The company offers a wide range of products for various conditions such as asthma, allergies, or diabetes. Additionally, Kyorin is dedicated to developing medications for rarer diseases such as Fabry disease or amyotrophic lateral sclerosis (ALS). Another important business area of Kyorin is medical devices and accessories. The company primarily focuses on devices for the diagnosis and treatment of respiratory diseases and allergies. This includes inhalers, peak flow meters, and allergy tests. Healthcare is another significant business area of Kyorin Holdings. The company offers products for maintaining and strengthening the immune system, such as dietary supplements and probiotics. Kyorin also provides cosmetic products made from plant-based ingredients. One of Kyorin's current projects is the development of peptide-based immunotherapies for cancer. The company has already achieved promising results in preclinical research and plans to continue clinical trials in the coming years. The corporate philosophy of Kyorin emphasizes the importance of research and development. The company invests a significant portion of its annual revenue in research and development and strives to find innovative solutions for disease treatment. Kyorin also values collaboration with other companies and research institutions. The company has formed partnerships with other pharmaceutical and medical technology companies to work together on the research and development of new products. Kyorin Holdings Inc is a company that focuses on the development and marketing of products that contribute to improving health and well-being. The company's various business areas allow it to target different audiences and meet the needs of patients and customers in various fields. With its long-standing experience in the pharmaceutical and medical technology sectors and its commitment to innovation and research, Kyorin remains an important player in healthcare and is dedicated to improving the quality of life for people worldwide. Kyorin Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Kyorin Pharmaceutical Co's Profit Margins

The profit margins of Kyorin Pharmaceutical Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Kyorin Pharmaceutical Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Kyorin Pharmaceutical Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Kyorin Pharmaceutical Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Kyorin Pharmaceutical Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Kyorin Pharmaceutical Co stock

How much profit has Kyorin Pharmaceutical Co made this year?

Kyorin Pharmaceutical Co has made 5.32 B JPY this year.

How has the profit developed compared to last year?

The profit has increased by 12.68% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Kyorin Pharmaceutical Co publish its earnings?

Kyorin Pharmaceutical Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Kyorin Pharmaceutical Co?

The profits of Kyorin Pharmaceutical Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Kyorin Pharmaceutical Co?

You can learn more about the earnings of Kyorin Pharmaceutical Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Kyorin Pharmaceutical Co pay?

Over the past 12 months, Kyorin Pharmaceutical Co paid a dividend of 52 JPY . This corresponds to a dividend yield of about 3.26 %. For the coming 12 months, Kyorin Pharmaceutical Co is expected to pay a dividend of 52.48 JPY.

What is the dividend yield of Kyorin Pharmaceutical Co?

The current dividend yield of Kyorin Pharmaceutical Co is 3.26 %.

When does Kyorin Pharmaceutical Co pay dividends?

Kyorin Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kyorin Pharmaceutical Co?

Kyorin Pharmaceutical Co paid dividends every year for the past 22 years.

What is the dividend of Kyorin Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 52.48 JPY are expected. This corresponds to a dividend yield of 3.29 %.

In which sector is Kyorin Pharmaceutical Co located?

Kyorin Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kyorin Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kyorin Pharmaceutical Co from 12/1/2024 amounting to 20 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Kyorin Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Kyorin Pharmaceutical Co in the year 2023?

In the year 2023, Kyorin Pharmaceutical Co distributed 52 JPY as dividends.

In which currency does Kyorin Pharmaceutical Co pay out the dividend?

The dividends of Kyorin Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kyorin Pharmaceutical Co

Our stock analysis for Kyorin Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kyorin Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.